Papers
2
Total Citations
140
H-Index
2
About
Dr. Tomoaki Kato is a pioneering hepatobiliary surgeon whose work has fundamentally reshaped the landscape of minimally invasive liver surgery. His primary research focuses on establishing the safety, efficacy, and oncologic equivalence of robotic liver resection (RLR) compared to traditional open surgery, particularly for hepatocellular carcinoma (HCC). Dr. Kato’s major contributions include providing critical, long-term outcome data that address the most debated topic in surgical oncology: whether robotic techniques can match open surgery in cancer control. His landmark 2022 study on robotic versus open liver resection for HCC, which has garnered 138 citations, offers compelling evidence on this front, demonstrating that the minimally invasive approach does not compromise oncologic integrity. Further solidifying his impact, Dr. Kato leads international efforts to standardize robotic procedures, as seen in his 2025 multicenter study establishing benchmark values for robotic right hepatectomy. By defining these performance standards from 22 expert centers, his work provides the essential framework for future comparisons and quality assurance. Through these high-impact studies, Dr. Kato is not just advancing a technique; he is building the evidence-based foundation that will guide the next generation of liver surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2